0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Treatment of Tinea Capitis with Orally Administered Griseofulvin

VICTOR D. NEWCOMER, M.D.; RICHARD S. HOMER, M.D.; RONALD M. REISNER, M.D.; LLOYD J. SORENSEN, Ph.D.; EARL G. McNALL, Ph.D.; THOMAS H. STERNBERG, M.D.
AMA Am J Dis Child. 1960;99(5):585-596. doi:10.1001/archpedi.1960.02070030587004.
Text Size: A A A
Published online

The changing epidemiological pattern of tinea capitis during the past two decades has emphasized the urgent need for an effective, simple, and relatively safe fungicidal agent. In this country, prior to 1940, approximately 80% of cases of tinea capitis were due to either Microsporum canis or Microsporum audouini. The number of cases of tinea capitis were comparatively small, and the incidence of disease due to these two organisms was approximately equal with local variations.1-4

During 1941 and 1942, in New York, there was observed a gradual increase in the number of cases of tinea capitis due to M. audouini. This gradual increase was followed, in 1943, by a sharp rise in the incidence of tinea capitis produced predominantly by this organism.1,4-6 In the ensuing five or six years the incidence of the disease produced by M. audouini increased to epidemic proportions and spread from New York to Albany,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();